1[1]Schellhorn C. Classification of quinolones by Ⅴ Andriole[J]. Infection, 1998,26(1):64.
2[2]Chu D T W,Fernandes P B. Structure-activity relationships of the fluoroquinolones[J]. Antimicrob Agents Chemother, 1989,33(2):131-135.
3[3]Stahlmann R,Lode H. Toxicity of quinolones[J]. Drugs,1999,58(suppl.2):37-42.
4[4]Stahlmann R,Schwabe R. Safety profile of grepafloxacin as compared with fluoroquinolones[J]. J Antimicrob Chemother, 1997,40(suppl.A):83-92.
5[5]Stahlmann R. Safety profile of the quinolones[J]. J Antimicrob Chemother, 1990, 26 (Suppl.D):31-44.
6[6]Akahane K,Sekiguchi M,Une T,et al. Structure-epileptogenicity relationships of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites[J]. Antimicrob Agents Chemother, 1989,33(10):1704-1708.
7[7]Robertson D G,Epling G A,Kiely J S, et al. Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound[J]. Toxicol Appl Pharmacol, 1991,111(2):221-232.
8[8]Giamarellou H,Kilokythas E,Petrikkos G,et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women[J]. Am J Med, 1989,87(suppl.5A):49-51.
9[9]Domagala J M.Structure-activity and structure-side-effect relationships for the quinolone antibacterials[J]. J Antimicrob Chemother, 1994,33(5):685-706.
10[10]Matsumoto M,Kana K,Hiroyuki N,et al. Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation[J]. Antimicrob Agents Chemother, 1992,36(8):1715-1719.
